Skip to main content
. 2017 Sep 23;8(54):92300–92311. doi: 10.18632/oncotarget.21247

Figure 4.

Figure 4

(A) Western blotting analysis for Col I and Col III expressions of activated PSCs were performed after 72h with CoQ10 treatment. (B) Quantification of western blots for Col I expressions of activated PSCs after 72h with CoQ10 treatment compared to control group (*: P<0.05. N=3). (C) Quantification of western blots for Col III expressions of activated PSCs after 72h with CoQ10 treatment compared to control group (*: P<0.05. N=3).